What about tocilizumab? A retrospective study from a NYC Hospital during the COVID-19 outbreak is a research paper published in PLoS ONE (2021). On theSindex it has a DataRank of 0. It has been cited 20 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph β no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full β never from an abstract alone.
National Institute of Allergy and Infectious Diseases
Grant: T32AI114398
NHLBI NIH HHS
Grant: K23 HL150280
NIAID NIH HHS
Grant: U01 AI069470
NHLBI NIH HHS
Grant: L30 HL143645
NIAID NIH HHS
Grant: T32 AI100852
NIAID NIH HHS
Grant: UM1 AI069470
National Institutes of Health
Grant: 1T32AI114398-01
Global HIV Implementation Science Research Training Grant
FWCI
1.18
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals